Skip to main content

Advertisement

SpringerLink
Log in

Benefit of theophylline administration in tacrolimus-induced nephrotoxicity in rats

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Tacrolimus (TAC), a widely used nephrotoxic calcineurin inhibitor, is associated with renal vasoconstriction possibly through adenosine receptor activation. Theophylline (THEO), an adenosine receptor inhibitor, protects against the nephrotoxicity of drugs associated with renal vasoconstriction. We hypothesized that coadministration of low dose THEO in rats would prevent TAC-induced nephrotoxicity. Sprague-Dawley rats pair-fed a low-sodium diet were randomized into three groups (n=10/group): the control (CONTROL) group received the vehicle for both medications; the TAC group received TAC 6 mg/kg/day and vehicle; and the TAC+THEO group received TAC and THEO 17 mg/kg/day. On day 21, a timed urine collection was obtained for creatinine clearance. On day 22, serum creatinine, THEO and whole blood TAC concentrations were determined. One kidney was removed for formalin fixation and histological assessment. In the TAC group, serum creatinine increased while creatinine clearance decreased compared to CONTROL (0.3±0.0 vs. 0.4±0.0 mg/dl and 0.53±0.06 vs. 0.34±0.04 ml/min/100 g body weight respectively, p<0.05), while TAC+THEO did not differ from control. There were no significant differences in renal histology. Concurrent administration of low-dose THEO prevented the TAC-induced decline in renal function, consistent with a role for adenosine in TAC-induced nephrotoxicity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.

Similar content being viewed by others

References

  1. Dumont F, Staruch MJ, Koprak SL, Sierkaka JJ (1992) The immunosuppressive and toxic effects of FK-506 are mechanistically related: pharmacology of a novel antagonist of FK-506 and rapamycin. J Exp Med 176:751–760

    CAS  PubMed  Google Scholar 

  2. Goldstein DJ, Zuech N, Sehgal V, Weinberg AD, Drusin R, Cohen D (1997) Cyclosporine-associated end-stage nephropathy after cardiac transplantation: incidence and progression. Transplantation 63:664–668

    CAS  PubMed  Google Scholar 

  3. Winkler M, Jost U, Ringe B (1991) Association of elevated FK506 plasma levels with nephrotoxicity in liver-grafted patients. Transplant Proc 23:3153–3155

    CAS  PubMed  Google Scholar 

  4. Messana JM, Johnson KJ, Mihatsch MJ (1995) Renal structure and function affects after low dose cyclosporine in psoriasis patients: a preliminary report. Clin Pathol 43:180–183

    Google Scholar 

  5. McDiarmid SV, Colonna JO II, Shaked A, Ament ME, Busuttil RW (1993) A comparison of renal function in cyclosporine and FK506-treated patients after primary orthotopic liver transplant. Transplantation 56:847–853

    CAS  PubMed  Google Scholar 

  6. Davies D, Bittmann I, Pardo J (2000) Histopathology of calcineurin inhibitor-induced nephrotoxicity. Transplantation 69:SS11–SS13

    CAS  PubMed  Google Scholar 

  7. Bagnis C, Deray G, Dubois M, Adabra Y, Jacquiaud C, Jaudon MC, Jacobs C (1997) Comparative acute nephrotoxicity of FK-506 and cyclosporine in an isolated in situ autoperfused rat model. Am J Nephrol 17:17–24

    CAS  PubMed  Google Scholar 

  8. Prevot A, Semama D, Tendron A, Justrabo E, Guignard JP, Gouyon JB (2000) Endothelin, angiotensin II, and adenosine in acute cyclosporine nephrotoxicity. Pediatr Nephrol 14:927–934

    Article  CAS  PubMed  Google Scholar 

  9. Guieu R, Dussol B, Devaux C, Sampol J, Brunet P, Rochat H, Bechis G, Berland YF (1998) Interactions between cyclosporine A and adenosine in kidney transplant recipients. Kidney Int 53:200–204

    Article  CAS  PubMed  Google Scholar 

  10. Hwang K, Hall CS, Spielman WS, Sparks HV (2001) FK506 promotes adenosine release from endothelial cells via inhibition of adenosine kinase. Eur J Pharmacol 425:85–93

    Article  CAS  PubMed  Google Scholar 

  11. Osswald H (1975) Renal effects of adenosine and their inhibition by theophylline in dogs. Naunyn Schmiedebergs Arch Pharmacol 288:79–86

    CAS  PubMed  Google Scholar 

  12. Osswald H, Gleiter C, Muhlbauer BP (1995) Therapeutic use of theophylline to antagonize renal effects of adenosine. Clin Nephrol 43:S33–S37

    PubMed  Google Scholar 

  13. Heidemann HT, Gerkens J, Jackson E, Branch RA (1983) Effect of aminophylline on renal vasoconstriction produced by amphotericin B in the rat. Naunyn Schmiedebergs Arch Pharmacol 324:140–152

    PubMed  Google Scholar 

  14. Heidemann HT, Muller S, Mertins L, Stepan G, Hoffmann K, Ohnhaus EE (1989) Effect of aminophylline in Cisplatin nephrotoxicity in the rat. Br J Pharmacol 97:313–318

    CAS  PubMed  Google Scholar 

  15. Erley C, Dauda S, Schlepckow S, Koehler J, Huppert RE, Strohmaier WL, Bohle A, Risler T, Osswald H (1994) Adenosine antagonist theophylline prevents reduction of glomerular filtration rate after contrast media application. Kidney Int 45:1425–1431

    CAS  PubMed  Google Scholar 

  16. Andoh T, Burdmann E, Lindsley J, Houghton DC, Bennett WM (1994) Enhancement of FK 506 nephrotoxicity by sodium depletion in an experimental rat model. Transplantation 57:483–489

    Google Scholar 

  17. Husdan H, Rappoport A (1968) Estimation of creatinine by the Jaffe reaction. A comparison of three methods. Clin Chem 14:222–238

    CAS  PubMed  Google Scholar 

  18. Dietemann J, Berthoux P, Gay-Montchamp JP, Batie M, Berthoux F (2001) Comparison of ELISA method versus MEIA method for daily practice in the therapeutic monitoring of tacrolimus. Nephrol Dial Transplant 16:2246–2249

    Article  CAS  PubMed  Google Scholar 

  19. Hanauer SB, Dassapoulos T (2001) Evolving treatment strategies for inflammatory bowel disease. Annu Rev Med 52:299–318

    Article  CAS  PubMed  Google Scholar 

  20. Assmann T, Homey B, Ruzicka T (2000) Applications of tacrolimus for the treatment of skin disorders. Immunopharmacology 47:203–213

    Article  CAS  PubMed  Google Scholar 

  21. Arai S, Vogelsang GB (2000) Management of graft-versus-host disease. Blood Rev 14:190–204

    Article  CAS  PubMed  Google Scholar 

  22. Fassi A, Sangalli F, Colombi F, Perico N, Remuzi G, Remuzzi A (1999) Beneficial effects of calcium channel blockade on acute glomerular hemodynamic changes induced by cyclosporine. Am J Kidney Dis 33:267–275

    CAS  PubMed  Google Scholar 

  23. Mitamura T, Yamada A, Ishida H, Fujihira S, Ohara K, Noguchi H, Mine Y (1994) Tacrolimus (FK506)-induced nephrotoxicity in spontaneous hypertensive rats. J Toxicol Sci 19:219–226

    CAS  PubMed  Google Scholar 

  24. Schrama YC, Koomans HA (1998) Interactions of cyclosporine A and amlodipine: blood cyclosporine a levels, hypertension and kidney function. J Hypertens 16:S33–S38

    CAS  Google Scholar 

  25. Raman GV, Campbell SK, Farrer A, Albano JDM, Cook J (1988) Modifying effects of amlodipine on cyclosporine A-induced changes in renal function in patients with psoriasis. J Hypertens 16:S39–S41

    Google Scholar 

  26. Van Riemsdijk I, Mulder PG, De Fijter JW, Bruijn JA, Van Hooff JP, Hoitsma AJ, Tegzess AM, Weimar W (2000) Addition of isradipine (lomir) results in a better renal function after kidney transplantation: double blind, randomized, placebo-controlled, multi-center study. Transplantation 70:122–126

    PubMed  Google Scholar 

  27. Osswald H, Schmitz HJ, Heidenreich O (1975) Adenosine response of the rat kidney after saline loading, sodium restriction and hemorrhagia. Pflugers Arch 357:323–333

    CAS  PubMed  Google Scholar 

  28. Potier M, Aparico M, Cambar J (1997) Protective effect of three xanthine derivatives (theophylline, caffeine and pentoxifylline) against the cyclosporine A-induced glomerular contraction in isolated glomeruli and cultured mesangial cells. Nephron 77:427–434

    CAS  PubMed  Google Scholar 

  29. Prevot A, Liet JM, Semama DS, Justrabo E, Guignard JP, Gouyon JB (2002) Disparate effects of chronic and acute theophylline on cyclosporine A nephrotoxicity. Pediatr Nephrol 17:418–424

    Article  CAS  PubMed  Google Scholar 

  30. Boubenider S, Vincent I, Lambotte O, Roy S, Hiesse C, Taburet AM, Charpentier B (2000) Interaction between theophylline and tacrolimus in a renal transplant patient. Nephrol Dial Transplant 15:1066–1068

    Article  CAS  PubMed  Google Scholar 

  31. Stillman I, Andoh T, Burdmann E (1995) FK 506 nephrotoxicity: morphologic and physiologic characterization of a rat model. Lab Invest 73:794–803

    CAS  PubMed  Google Scholar 

  32. Matsuda H, Iwasaki K, Shiraga T (1996) Interactions of FK506 (TAC) with clinically important drugs. Res Commun Mol Pathol Pharmacol 91:57–64

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported in part by a grant from the Kidney Foundation of South Florida.

Author information

Authors and Affiliations

  1. Department of Pediatrics, University of Miami School of Medicine, Miami, FL 33101, USA

    Gwenn E. McLaughlin, Michelle Schober & Carolyn Abitbol

  2. Department of Pathology, University of Miami School of Medicine, Miami, FL 33101, USA

    Maria Perez, Phillip Ruiz & Bernard W. Steele

  3. Department of Pediatrics, Division of Pediatric Critical Care Medicine, University of Miami School of Medicine, PO Box 016960 (R-131), Miami, FL 33101, USA

    Gwenn E. McLaughlin

Authors
  1. Gwenn E. McLaughlin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michelle Schober
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Maria Perez
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Phillip Ruiz
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Bernard W. Steele
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Carolyn Abitbol
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gwenn E. McLaughlin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

McLaughlin, G.E., Schober, M., Perez, M. et al. Benefit of theophylline administration in tacrolimus-induced nephrotoxicity in rats. Pediatr Nephrol 18, 860–864 (2003). https://doi.org/10.1007/s00467-003-1196-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-003-1196-z

Keywords

Search

Navigation